Invention Grant
- Patent Title: Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
-
Application No.: US15486836Application Date: 2017-04-13
-
Publication No.: US10253020B2Publication Date: 2019-04-09
- Inventor: Jamal Tazi , Florence Mahuteau , Pierre Roux , Romain Najman , Didier Scherrer , Carsten Brock , Nathalie Cahuzac , Gilles Gadea , Noelie Campos , Aude Garcel , Julien Santo
- Applicant: ABIVAX , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT CURIE , UNIVERSITE DE MONTPELLIER
- Applicant Address: FR Paris FR Paris FR Paris FR Montpellier
- Assignee: ABIVAX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT CURIE,UNIVERSITE DE MONTPELLIER
- Current Assignee: ABIVAX,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT CURIE,UNIVERSITE DE MONTPELLIER
- Current Assignee Address: FR Paris FR Paris FR Paris FR Montpellier
- Agency: Oliff PLC
- Priority: EP09162630 20090612; EP09305540 20090612
- Main IPC: C07D215/38
- IPC: C07D215/38 ; C07D217/02 ; C07D241/44 ; C07D401/12 ; C07D403/12 ; C07D413/04 ; A61K31/47 ; A61K31/496

Abstract:
The manufacture and use of compounds of formula (Ia) or a pharmaceutically acceptable salt thereof for preventing, inhibiting or treating cancer, AIDS and/or premature aging. The compounds of formula (Ia) being: where: R independently represents a hydrogen atom, a halogen atom, a (C1-C3)alkyl group, a —CN group, a hydroxyl group, a —COOR1 group, a (C1-C3)fluoroalkyl group, a —NO2 group, a —NR1R2 group, or a (C1-C3)alkoxy group; R′ is a hydrogen atom, a halogen atom, a (C1-C3)alkyl group, a —NO2 group, a (C1-C3)alkoxy group, or a —NR1R2 group; and R1 and R2 are a hydrogen atom or a (C1-C3) alkyl group.
Public/Granted literature
- US20170226095A1 COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING Public/Granted day:2017-08-10
Information query